Sort   by:  
 Page size 
UnknownEpimutational profile of hematologic malignancies as attractive target for new epigenetic therapies.
Not available
S-EPMC5302993 | biostudies-literature
UnknownToll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma.
Not available
S-EPMC4849792 | biostudies-literature
UnknownPhospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma.
Not available
S-EPMC5173105 | biostudies-literature
UnknownTracking attosecond electronic coherences using phase-manipulated extreme ultraviolet pulses.
Not available
S-EPMC7021897 | biostudies-literature
UnknownWhole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients.
Not available
S-EPMC3539917 | biostudies-literature
UnknownImmunomodulatory activity of SGI-110, a 5-aza-2'-deoxycytidine-containing demethylating dinucleotide.
Not available
S-EPMC11029398 | biostudies-literature
UnknownThe pleiotropic roles of circular and long noncoding RNAs in cutaneous melanoma.
Not available
S-EPMC8807361 | biostudies-literature
UnknownCXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells.
Not available
S-EPMC3008677 | biostudies-literature
UnknownEpigenetic remodelling of gene expression profiles of neoplastic and normal tissues: immunotherapeutic implications.
Not available
S-EPMC3461156 | biostudies-literature
UnknownLoss of Spry1 reduces growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy.
Not available
S-EPMC7244546 | biostudies-literature
Sort   by:  
 Page size